¼¼°èÀÇ À籸¼º ¾à¹°¿ë ¹ÙÀÌ¾Ë ¾î´ðÅÍ ½ÃÀå º¸°í¼­(2025³â)
Vial Adaptors For Reconstitution Drug Global Market Report 2025
»óǰÄÚµå : 1760736
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,312,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,124,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,936,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À籸¼º ¾à¹°¿ë ¹ÙÀÌ¾Ë ¾î´ðÅÍ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È 10.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 2029³â±îÁö 30¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ »ç¿ë Áõ°¡, ÀçÅÃÄ¡·á ¹× ÀÚ°¡ Åõ¿© Áõ°¡, ¼¼°è Àα¸ÀÇ °í·ÉÈ­, Á¾¾çÇÐ ¹× Èñ±ÍÁúȯ Ä¡·áÀÇ ¼ºÀå, ±³Â÷ ¿À¿° À§Çè¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡¿¡ ÀÇÇØ µÞ¹ÞħµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ½º¸¶Æ® ±â¼úÀÇ ÅëÇÕ, Àç·á °úÇÐÀÇ ¹ßÀü, ÀçÅÃÄ¡·á ¹× ÀÚ°¡ Åõ¿©¸¦ À§ÇÑ ¸ÂÃãÈ­, Áö¼Ó °¡´ÉÇϰí ȯ°æ ģȭÀûÀÎ Àç·áÀÇ Ã¤ÅÃ, ÀǾàǰ Æ÷ÀåÀÇ Áö¼Ó°¡´É¼º °­Á¶ µîÀÌ ÀÖ½À´Ï´Ù.

¸¸¼º Áúȯ Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È À籸¼º ¾à¹°¿ë ¹ÙÀÌ¾Ë ¾î´ðÅÍ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸¸¼ºÁúȯÀº Áö¼ÓÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇϰí 1³â ÀÌ»ó Áö¼ÓµÉ ¼ö ÀÖ´Â Àå±âÀûÀÎ °Ç°­ »óÅÂÀÔ´Ï´Ù. ¸¸¼ºÁúȯ Áõ°¡´Â °¡°ø½ÄǰÀÇ ¼Òºñ¿Í ÁÂ½Ä »ýȰ½À°ü Áõ°¡·Î ÀÎÇØ ½ÅüÀÇ ÀÚ¿¬Àû ¹æ¾î·ÂÀ» ¾àÈ­½ÃÄÑ Àå±âÀûÀÎ °Ç°­ ¹®Á¦ÀÇ ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. »ý¹°ÇÐÀû Á¦Á¦ ¹× µ¿°á°ÇÁ¶ Á¦Á¦¸¦ ¾ÈÀüÇϰí È¿À²ÀûÀ¸·Î À籸¼ºÇϰí Åõ¿©Çϱâ À§ÇØ ¸¸¼ºÁúȯ Ä¡·á¿¡´Â ÀϹÝÀûÀ¸·Î À籸¼º ¾à¹°¿ë ¹ÙÀÌ¾Ë ¾î´ðÅͰ¡ »ç¿ëµÇÁö¸¸, ÀÌ´Â Á¾Á¾ Àå±â°£ÀÇ Ä¡·á ±â°£ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 7¿ù ¿µ±¹ÀÇ µ¶¸³ ÀÚ¼±´ÜüÀÎ The Health FoundationÀº 2040³â±îÁö ¿µ±¹¿¡¼­ 910¸¸ ¸íÀÌ Å« Áúº´À» ¾Î°í ÀÖÀ¸¸ç, ÀÌ´Â ÇöÀ纸´Ù 250¸¸ ¸íÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí À籸¼º ¾à¹°¿ë ¹ÙÀÌ¾Ë ¾î´ðÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À籸¼º ¾à¹° ¹ÙÀÌ¾Ë ¾î´ðÅÍ ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº È¥ÇÕ ÁÖÀÔ ÀåÄ¡¿Í °°Àº ÷´Ü Á¦Ç° °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ¾à¹° À籸¼ºÀÇ Á¤È®¼ºÀ» ³ôÀ̰í, ¿À¿° À§ÇèÀ» ÃÖ¼ÒÈ­Çϸç, ¾à¹° Áغñ ¹× Åõ¿©ÀÇ Àü¹ÝÀûÀÎ È¿À²¼ºÀ» Çâ»ó½Ã۵µ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. È¥ÇÕ ÁÖÀÔ ÀåÄ¡´Â ÀǾàǰ, ƯÈ÷ »ý¹°ÇÐÀû Á¦Á¦³ª µ¿°á°ÇÁ¶ ÀǾàǰÀ» »ç¿ë Àü¿¡ Èñ¼®Á¦¿Í °áÇÕÇÏ¿© ¾ÈÀüÇϰí Á¤È®ÇÏ°Ô È¥ÇÕÇϰųª À籸¼ºÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ´Â ÀÇ·á¿ë µµ±¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 12¿ù, ¹Ì±¹¿¡ º»»ç¸¦ µÐ Çõ½ÅÀûÀÎ ÁÖ»çÁ¦ Àü´Þ ½Ã½ºÅÛÀ» Á¦°øÇÏ´Â West Pharmaceutical Services, Inc.´Â Vial2Bag Advanced 13mm È¥ÇÕ ÀåÄ¡(Vial2Bag Advanced 13mm)¿¡ ´ëÇÑ FDA 510(k) ½ÂÀÎÀ» ȹµæÇß½À´Ï´Ù. ÀÌ ½ÅÁ¦Ç°Àº ±âÁ¸ 20mm ¹öÀüÀ» º¸¿ÏÇÏ´Â Á¦Ç°À¸·Î, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô 13mm ¶Ç´Â 20mm ¹ÙÀÌ¾Ë ¹× IV ¹éÀ» »ç¿ëÇÏ¿© ¾à¹°À» À籸¼ºÇϰí ÁÖÀÔÇÒ ¼ö ÀÖ´Â À¯¿¬ÇÏ°í ¹Ù´ÃÀÌ ÇÊ¿ä ¾ø´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. È¿À²ÀûÀÎ À¯Ã¼ °æ·Î¸¦ À§ÇÑ µà¾ó ä³Î ¼³°è¿Í °ß°íÇÑ ¹ÙÀÌ¾Ë ½ºÆÄÀÌÅ©(vial spike)¸¦ ÅëÇØ ¾ÈÀüÇÑ ¿¬°áÀ» º¸ÀåÇÏ´Â ÀÌ ÀåÄ¡´Â ÀÓ»ó ÇöÀå¿¡¼­ÀÇ ¾ÈÀü¼º°ú »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ãŵ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í ÄڷγªÀç³­°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Vial adaptors for reconstitution drugs are medical devices designed to safely and efficiently mix a powdered medication in a vial with a diluent prior to administration. They aim to reduce contamination risk, ensure accurate dosing, and streamline the drug preparation process for healthcare professionals.

The main product categories include single-use vial adaptors, multi-use vial adaptors, and customized vial adaptors. Single-use vial adaptors are sterile, disposable devices intended for safe medication transfer or reconstitution from a vial for a single use, promoting contamination prevention and patient safety. These adaptors are manufactured using materials such as polycarbonate, silicone, polyethylene, and others, and are applied in areas such as oncology, autoimmune disorders, infectious diseases, genetic conditions, and hormone replacement therapy. Primary end users include pharmaceutical companies, contract manufacturing organizations, research institutions, hospitals, and retail pharmacies.

The vial adaptors for reconstitution of drug market research report is one of a series of new reports from The Business Research Company that provides vial adaptors for reconstitution of drug market statistics, including the vial adaptors for reconstitution of drug industry global market size, regional shares, competitors with the vial adaptors for reconstitution of drug market share, detailed vial adaptors for reconstitution of drug market segments, market trends, and opportunities, and any further data you may need to thrive in the vial adaptors for reconstitution of drug industry. This vial adaptors for reconstitution of drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vial adaptors for reconstitution drug market size has grown rapidly in recent years. It will grow from $1.81 billion in 2024 to $2.01 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. Growth during the historic period was driven by the rising prevalence of chronic diseases, increasing demand for safe drug administration, expansion of parenteral drug use, development of hospital and healthcare infrastructure, and greater adoption of single-dose vials.

The vial adaptors for reconstitution drug market size is expected to see rapid growth in the next few years. It will grow to $3.05 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. Growth in the forecast period is expected to be supported by the increasing use of biologics and biosimilars, the rise of home healthcare and self-administration, an aging global population, growth in oncology and rare disease treatments, and heightened awareness of cross-contamination risks. Key trends anticipated for the forecast period include the integration of smart technologies, advances in material science, customization for home healthcare and self-use, adoption of sustainable and eco-friendly materials, and a focus on sustainability in pharmaceutical packaging.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the vial adaptors for reconstitution drug market in the coming years. Chronic diseases are long-term health conditions that require ongoing medical care and can persist for a year or more. The rise in chronic conditions is largely due to the growing consumption of processed foods and sedentary lifestyles, which weaken the body's natural defenses and contribute to long-term health issues. Vial adaptors for reconstitution drugs are commonly used in the treatment of chronic diseases to safely and efficiently reconstitute and administer biologic or lyophilized medications, which are often required for extended treatment periods. For example, in July 2023, The Health Foundation, a UK-based independent charity, projected that by 2040, 9.1 million people in England will be living with a major illness, an increase of 2.5 million from current figures. As a result, the rising incidence of chronic diseases is expected to drive demand for vial adaptors for reconstitution drugs.

Major players in the vial adaptors for reconstitution drug market are focusing on developing advanced products such as admixture devices. These devices are designed to enhance the precision of drug reconstitution, minimize contamination risks, and improve overall efficiency in preparing and administering medications. An admixture device is a medical tool that facilitates the safe and accurate mixing or reconstitution of drugs, especially biologics or lyophilized medications, by combining the drug with a diluent before use. For instance, in December 2023, West Pharmaceutical Services, Inc., a U.S.-based provider of innovative injectable drug delivery systems, received FDA 510(k) clearance for its Vial2Bag Advanced 13mm admixture device. This new product complements the existing 20mm version, offering healthcare providers flexible, needle-free solutions for drug reconstitution and transfer with either 13mm or 20mm vials and IV bags. Featuring a dual-channel design for efficient fluid pathways and a robust vial spike for secure connection, the device improves safety and ease of use in clinical settings.

In November 2024, Amsino Medical Group, a U.S.-based medical device manufacturer, acquired MedXL Inc. for an undisclosed amount. This acquisition allows Amsino to significantly increase its production capacity, enabling the company to meet the growing demand for medical devices, including vial adapters. The expanded manufacturing capabilities will help Amsino continue to supply high-quality medical products to healthcare providers. MedXL Inc. is a Canada-based manufacturer specializing in vial adapters for drug reconstitution.

Major players in the vial adaptors for reconstitution drug market are Medline Industries LP, Becton Dickinson and Company, Baxter International Inc., B. Braun SE, Nipro Corporation, West Pharmaceutical Services Inc., Stevanato Group S.p.A., Miltenyi Biotec B.V. & Co. KG, Vygon SA, Helapet Limited, Union Plastic S.A.S., MedXL Inc., Amsino International Inc., Simplivia Healthcare Ltd., Yukon Medical LLC, Corvida Medical Inc., Dedecke GmbH, Medtec Medical Inc., APG Pharma B.V., and Conserva UK Limited.

North America was the largest region in the vial adaptors for reconstitution drug market in 2024. The regions covered in vial adaptors for the reconstitution drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vial adaptors for the reconstitution drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vial adaptors for the reconstitution drug market consist of sales of closed-system vial adaptors, Luer-lock vial adaptors, universal vial adaptors, and vented vial adaptors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vial Adaptors For Reconstitution Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vial adaptors for reconstitution drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for vial adaptors for reconstitution drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vial adaptors for reconstitution drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Vial Adaptors For Reconstitution Drug Market Characteristics

3. Vial Adaptors For Reconstitution Drug Market Trends And Strategies

4. Vial Adaptors For Reconstitution Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Vial Adaptors For Reconstitution Drug Growth Analysis And Strategic Analysis Framework

6. Vial Adaptors For Reconstitution Drug Market Segmentation

7. Vial Adaptors For Reconstitution Drug Market Regional And Country Analysis

8. Asia-Pacific Vial Adaptors For Reconstitution Drug Market

9. China Vial Adaptors For Reconstitution Drug Market

10. India Vial Adaptors For Reconstitution Drug Market

11. Japan Vial Adaptors For Reconstitution Drug Market

12. Australia Vial Adaptors For Reconstitution Drug Market

13. Indonesia Vial Adaptors For Reconstitution Drug Market

14. South Korea Vial Adaptors For Reconstitution Drug Market

15. Western Europe Vial Adaptors For Reconstitution Drug Market

16. UK Vial Adaptors For Reconstitution Drug Market

17. Germany Vial Adaptors For Reconstitution Drug Market

18. France Vial Adaptors For Reconstitution Drug Market

19. Italy Vial Adaptors For Reconstitution Drug Market

20. Spain Vial Adaptors For Reconstitution Drug Market

21. Eastern Europe Vial Adaptors For Reconstitution Drug Market

22. Russia Vial Adaptors For Reconstitution Drug Market

23. North America Vial Adaptors For Reconstitution Drug Market

24. USA Vial Adaptors For Reconstitution Drug Market

25. Canada Vial Adaptors For Reconstitution Drug Market

26. South America Vial Adaptors For Reconstitution Drug Market

27. Brazil Vial Adaptors For Reconstitution Drug Market

28. Middle East Vial Adaptors For Reconstitution Drug Market

29. Africa Vial Adaptors For Reconstitution Drug Market

30. Vial Adaptors For Reconstitution Drug Market Competitive Landscape And Company Profiles

31. Vial Adaptors For Reconstitution Drug Market Other Major And Innovative Companies

32. Global Vial Adaptors For Reconstitution Drug Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vial Adaptors For Reconstitution Drug Market

34. Recent Developments In The Vial Adaptors For Reconstitution Drug Market

35. Vial Adaptors For Reconstitution Drug Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â